Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
about
Invasion and metastasis in pancreatic cancerGastrointestinal hormones cause rapid c-Met receptor down-regulation by a novel mechanism involving clathrin-mediated endocytosis and a lysosome-dependent mechanismPAK4 interacts with p85 alpha: implications for pancreatic cancer cell migrationPancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer modelNK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cellsStromal biology of pancreatic cancer.Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts.Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma.Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells.FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma.Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
P2860
Q28473066-82D3AA95-D675-4954-BA0E-D0701341BDC6Q54750736-B6E2D1E9-E66F-4BC3-A08C-C9007B3C442AQ54897588-F7734E3E-F76A-4255-B2BE-BB201BE9D7E6Q54897589-D2CD7E08-134E-4591-9E46-9D0CB8829286Q54907231-636EDCA7-58A6-447E-9841-3E2A08BF01B4Q54907232-DEBA044C-56E2-4436-A7B9-121E833EC8DEQ54907233-85B3EFC1-03B5-47BC-A1C8-552BE98B52FAQ54951495-A4F00851-A9CE-4B2F-B9FD-983E1C7AA449Q54951496-DEB3C840-AC77-4A8B-9477-BB8F141052FAQ54954514-7B73AD3A-019E-405D-ACBC-91F9AAB176ECQ54954517-5B12A3BA-8C3A-4651-A462-5B7F0F20435C
P1343
Q24800065-F0AD7C78-F4A6-4833-87A5-7FB51988D422Q28570307-89860896-3347-4BAC-AAEA-1E95BEB62740Q30838867-9DACAAAA-D5DC-473E-BC0B-F44E5679B41FQ35130515-7BD67C92-CB35-423E-BA30-22B25FB4E4EAQ35605388-61D3990D-7CED-4763-A370-351AD588557EQ36622822-2D6225CE-37C3-4489-ADEF-8CAAC35C645EQ36723725-B81D975E-EE7E-4F6F-8A4D-494AC8F9C735Q36789093-00D95899-3205-46EA-9ED5-E3D51C98D8BDQ37711135-31CD0703-E170-4B28-A9A6-37EA616D490FQ39825114-2F832927-66A6-4B66-8B0F-A41155FD7E34Q39870326-6053919D-BA26-4271-9A08-2CDC30339CECQ40431244-4B64FE8B-FCC2-4117-9C70-90A068864CC8Q40449553-719F4A53-59EC-46C2-B37A-65D06DD825B6Q40470278-79282E22-2358-4CD9-BD37-25657FBC5701Q40503987-98D7B491-7144-4093-B3EF-B725B4C5E714Q40564959-338F7F80-441B-49AB-BD05-13824670095FQ40704803-74832F6B-08D8-49FF-B3D8-34D503AA9366Q41205527-9066E95A-9BC5-49F1-B830-58331C182432Q43824447-EE490518-0C12-4FD4-BA35-8A0389712AB4Q45870062-5147F963-1B4C-4ABE-98A8-66DCB9EA163EQ52575847-D3970222-8E9D-4530-877E-CE85FFDFF763Q52638887-97D1D4F7-52F4-4E56-9368-E006B64E49F4Q53538335-409F6325-1178-4449-86C9-8CD2F2C95B63
P2860
Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Activation of the urokinase pl ...... umor cells overexpressing Met.
@ast
Activation of the urokinase pl ...... umor cells overexpressing Met.
@en
type
label
Activation of the urokinase pl ...... umor cells overexpressing Met.
@ast
Activation of the urokinase pl ...... umor cells overexpressing Met.
@en
prefLabel
Activation of the urokinase pl ...... umor cells overexpressing Met.
@ast
Activation of the urokinase pl ...... umor cells overexpressing Met.
@en
P2093
P2860
P4510
P921
P1476
Activation of the urokinase pl ...... umor cells overexpressing Met.
@en
P2093
R Paciucci
T Nakamura
P2860
P304
P356
10.1016/S0002-9440(10)65561-7
P407
P577
1998-07-01T00:00:00Z